baber/WOPTO huggingface dataset:
Patent NZ-336817-A (NZ)
Title: Acrylonitrile compounds, process for their production and pesticides containing them
Inventor: KOYANAGI TORU
IPC: A01N43/08
Filed: 1998-02-13
Abstract: An acrylonitrile compound of the following formula (I) or its salt:  wherein Q is selected from Qa, Qb, Qc & Qd  Y is =C(R4)- or =N-,  R1 is alkyl, haloalkyl, alkoxyalkyl, alkylthioalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, -C(=O)R5, -C(=S)R5, -S(O)WR5 or -CH2Rg,  each of R2 and R3 is halogen, alkyl, alkenyl, alkynyl, alkoxy, alkenyloxy, alkynyloxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkenylthio, alkenylsulfinyl, alkenylsulfonyl, alkynylthio, alkynylsulfinyl, alkynylsulfonyl, nitro, cyano, , phenoxy, phenylthio, phenylsulfinyl, phenylsulfonyl, benzyl, benzyloxy, benzylthio, or benzoyl,  R4 is hydrogen, halogen, alkyl or haloalkyl,  R5 is alkyl, alkenyl, alkynyl, alkoxy, alkenyloxy, alkynyloxy, alkylthio, alkenylthio, alkynylthio, cycloalkyl, cycloalkyloxy, cycloalkylthio, -N(R7)R8, phenyl, phenoxy, phenylthio, benzyl, benzyloxy, benzylthio, -J, -O-J or -S-J,  each of R7 and R8 is hydrogen, alkyl or alkoxy,  R9 is cyano, phenyl, phenoxy, phenylthio, phenylsulfinyl, phenylsulfonyl, benzyl, benzyloxy, benzylthio, benzoyl, -J, -C(=O)R10, -C(=S)R10, -S(O)WR10 or trimethylsilyl,  R10 is alkyl or alkoxy,  J is a 5- or 6-membered heterocyclic group containing from 1 to 4 hetero atoms of at least one type selected from the group consisting of O, S and N,  m is from 0 to 5, n is from 0 to 3, q is from 0 to 4, w is from 0 to 2, provided that the following compounds are excluded (1)	a compound wherein Q is Qb, Y is =C(R4)-, and R1 is alkyl, haloalkyl, alkoxyalkyl, alkylthioalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, -S(O)WR5 or -CH2Rg, (2)	(2) a compound wherein Q is Qb, Y is =C(R4)-, R1 is -C(=O)R5, and R5 is alkyl, alkenyl, alkynyl, alkoxy, alkenyloxy, alkynyloxy, cycloalkyl, cycloalkyloxy, -N(R7)R8, phenyl, phenoxy, phenylthio, benzyl, benzyloxy, benzylthio, -J, -O-J or -S-J, (3)	a compound wherein Q is Qb, Y is =C(R4)-, R1 is -C(=S)R5, and R5 is -N(R7)R8, (4)	a compound wherein Q is Qb or Qc, Y is =N-, R1 is alkyl or -C(=O)R5, and R5 is alkyl, (5)	(5) 3-(4-chlorophenyl)-2phenyl-3-ethoxyacrylonitrile, (6)	(6) 2-(3,5 dimethoxyphenyl)-3-(2-methoxy-4-methylphenyl)-3acetoxyacrylonitrile, and (7)	(7) 2-(3,5-dimethoxyphenyl)-3 (2,6-dimethoxy-4-methylphenyl)-3-acetoxyacrylonitrile.
Patent NZ-338086-A (NZ)
Title: Biaxially stretched, heat shrinkable polymeric film comprising three copolymers, blends and process for foods
Inventor: TATARKA PAUL DAVID
IPC: B29C55/28
Filed: 1999-09-28
Abstract: A flexible biaxially stretched heat shrinkable polymeric film having at least one layer comprising a blend of at least three copolymers comprising: a) 20-85 weight percent polymer with a melt point of 80-98oC with one copolymer of ethylene and hexene-1; a) 5-35 weight percent of a second polymer with a melt point of 115-128oC with at least one copolymer of ethylene and one á-olefin; b) 10-50 weight percent of a third polymer with a melt point of 60-110oCwith at least one copolymer of ethylene and a vinyl ester, an alkyl acrylate, acrylic acid or metharcylic acid; wherein the first and second polymers have combined weight percentage of 50.
Patent NZ-500637-A (NZ)
Title: N-5-(phenyl)-triazolyl-2-indolecarboxamide derivatives useful as CCK-A agonists
Inventor: BIGNON ERIC
IPC: A61K31/41
Filed: 1998-05-06
Abstract: The N-5-(phenyl)-triazolyl-2-indolecarboxamide derivatives or its salts or solvates have formula I wherein: R1 is alkyl, -(CH2)m-G, optionally substituted phenylalkyl or  -(CH2)n-NR2R3; n is 1 to 6; R2 and R3 are independently alkyl or NR2R3 together forms a morpholino, piperidino, pyrrolidinyl or piperazinyl; m is 0-5; G is a non-aromatic optionally alkyl substituted mono or polycyclic hydrocarbon; X1 to X4 are independently H, halogen, alkyl, alkoxy or CF3 with only one of X1 to X4 can be H; R4 is H, -(CH2)n-COOR5, alkyl, -(CH2)n-OR5, (CH2)nNR2R3, -(CH2)n-tetrazolyl or R4 is one of these groups in the form of an alkali metal or alkaline earth metal salt; R5 is H, alkyl or aralkyl; Y1 to Y3 is H, halogen, alkyl, alkoxy, nitro, cyano, acylamino, carbamoyl, CF3 or COOR6; R6 is H or alkyl;  A pharmaceutical composition thereof is useful to treat obesity, tardive dyskinesia or to reduce the intake of food.
Patent NZ-502260-A (NZ)
Title: Microtablets of an analgesic having a diameter of less than 3mm
Inventor: BARTHOLOMAUS JOHANNES
IPC: A61K9/48
Filed: 2000-01-11
Abstract: An controlled release oral administered preparation contains microtablets of <3 mm of at least one analgesic provided that the analgesic is not paracetamol.
Patent NZ-505699-A (NZ)
Title: Tap with incorporated air passageway
Inventor: WOODWARD IAN
IPC: B67D3/04
Filed: 1999-01-15
Abstract: A tap comprising a body having a liquid flow passageway between a liquid inlet (10) and a liquid outlet (12) and an air flow passageway between an air inlet (13) and an air outlet (10). A valve system including a valve seat (24) is provided for controlling liquid and air flow in the passageways which is operated by a push button (16).  When the air inlet (not shown) and liquid outlet (not shown) are coincident, the valve seat (not shown) may be at or adjacent the liquid outlet (not shown). When the air outlet (10) and liquid inlet (10) are coincident, the valve seat (24) may be at the liquid inlet (10).
Patent NZ-507213-A (NZ)
Title: Tapered wall teat cup liner for a milking machine
Inventor: BRIGGS STEPHEN WILLIAM
IPC: A01J5/08
Filed: 1999-03-23
Abstract: A teat cup liner for milking domestic animals such as cows and goats. The liner (1) comprises, an opening (8) into which an animal's teat (70) may be inserted, an outlet (6) for discharging milk from the animal, a teat engaging portion (10) with annular walls (7, 107), a collapsible portion having relatively thinner inner walls (13, 113) and sealing means (60, 66) for a teat cup shell (32) between which lies all of the collapsible portion (12) so a vacuum pressure may be applied to a teat cup assembly (30) to milk the animal.  The distance from the opening (8) to a point (76) at which the collapsible portion (12) collapses is sufficient so that the collapsible portion (12) collapses completely away from the animal's teat (70).  The collapsible portion (12) has an elongate cross section, having a tapering section (17) between the teat engaging portion (10) and the collapsible portion (12).  The tapering portion (17) has outer and inner walls (11, 111), the thickness of which tapers more gradually along a minor cross-sectional axis than along a major cross-sectional axis, so that the tapering section (17) may collapse gently on the teat (70) as the collapsible portion (12) collapses.
Patent NZ-509505-A (NZ)
Title: Medicaments containing bisphosphonic acids and derivatives thereof which are provided for preventing and treating autoimmune diseases and allergies
Inventor: JOMAA HASSAN
IPC: A61K45/06
Filed: 1999-06-24
Abstract: Use of bisphosphonic acid compounds of formula (I) and their salts, esters or prodrugs for the treatment and prevention of autoimmune disorders, wherein; A1, A2, A3, A4 are hydrogen, optionally substituted alkyl, aryl, aralkyl, cycloalkyl or heterocyclyl, a metal from the first, second or third main group of the periodic table or an ammonium group or substituted ammonium moiety, which is derived from ethylenediamine or an amino acid; X is alkylene, alkenylene or hydroxyalkylene, or a bond; R1, R2 are H, OH, NH2, optionally substituted alkyl, acyl, aryl, aralkyl, cycloalkyl or heterocyclyl, SR3, Cl or NR3R4; and R3, R4 are H, OH, or optionally substituted alkyl, acyl, aryl, aralkyl, cycloalkyl or heterocyclyl. Bisphosphonic acid compounds of formula (I), when co-administered with autoantigens or allergens, act synergistically to treat a range of autoimmune disorders.
Patent NZ-509619-A (NZ)
Title: Synthesis of alkyl cyclopentadienyl) metallocenes and their conversion to bis(alkyl cyclopentadienyl) metallocenes
Inventor: SULLIVAN JEFFREY M
IPC: C07F3/02
Filed: 2000-05-30
Abstract: Described is a method for producing an alkyl cyclopentadiene by reacting cyclopentadienyl Grignard with an alkyl halide and for converting the alkyl cyclopentadiene to a bis(n-alkyl cyclopentadienyl) Group IV metal dihalide.
Patent NZ-511170-A (NZ)
Title: Administering anitgens for protection against Salmonella infections
Inventor: HOLDEN DAVID WILLIAM
IPC: C12N15/31
Filed: 1995-12-11
Abstract: A method for preventing microbial infection or vaccinating a non-human host comprises administrating a mutant bacterium wherein if the bacterium normally contains a gene that is the same of functionally equivalent to a gene in VGC2, or contains a virulence gene comprising a sequence identified as SEQ ID NO:8-36, a Salmonella sequence shown in Figure 5 or SEQ ID NO:37-38 the gene is mutated or absence. Also described are methods of making a mutant microorganism, mutant bacterium and methods of using the mutant bacterium in the manufacture of medicaments for preventing microbial infection or for vaccinating a host against a pathogen. (62) Divided out of 296581
Patent NZ-511379-A (NZ)
Title: Platelet-derived growth factor D (PDGF-D), DNA coding therefor, and uses thereof for invasions of tumor cells
Inventor: ERIKSSON ULF
IPC: A61P35/00
Filed: 1999-11-10
Abstract: PDGF-D, a new member of the PDGF/VEGF family of growth factors, is described, as well as the nucleotide sequence encoding it, methods for producing it, antibodies and other antagonists to it, transfected and transformed host cells expressing it, pharmaceutical compositions containing it, and uses thereof in medical and diagnostic applications. It is useful for stimulating growth of connective tissue, wound healing, inhibiting tumor growth and inhibiting tissue remodelling during invasion of tumor cells.
Patent NZ-511611-A (NZ)
Title: Pharmaceutical composition for modified release of insulin sensitiser
Inventor: SAUER JOSEPH
IPC: A61K9/50
Filed: 1999-11-12
Abstract: A modified release pharmaceutical composition comprises 2 to 8 mg of 5-[4-[2-(N-methyl-N-2- pyridyl)amino)ethoxy)]benzyl]thiazolidine-2,4-dione or a pharmaceutically acceptable derivative and a pharmaceutically acceptable carrier. The composition can be formulated to provide delayed, pulsed or sustained release of the active ingredient.
Patent NZ-512444-A (NZ)
Title: Modular power supply for generating a high voltage DC output
Inventor: CROSS JAMES D
IPC: H02M7/10
Filed: 1999-10-26
Abstract: A power supply for producing a high voltage DC output. The power supply comprises a primary winding and a series of secondary stages each having secondary windings coupled to the primary winding through a magnetic circuit. Each secondary stage comprises a printed circuit board with the secondary windings formed as a series of independent coils or turns on the board substrate. The magnetic circuit comprises a series of segments which are separated by an insulating film to maintain each segment at the same potential as the associated printed circuit board. Each coil includes a rectifier element for converting the induced AC voltage into a DC voltage. The rectifier elements are connected in series and the printed circuit boards are coupled to produce a high level DC voltage output signal, for example, a minimum 200 kV output. To compensate for Magneto Motive Force (MMF) losses through the insulating film, the rectifier elements include a compensation capacitor.
Patent NZ-514620-A (NZ)
Title: Genetic modification of somatic cells and uses thereof
Inventor: COLMAN ALAN
IPC: C12N15/10
Filed: 2000-03-03
Abstract: A method of preparing a somatic cell for nuclear transfer comprising modifying the genetic material of the somatic cell by a genetic targeting event at an endogenous locus, then transferring the genetic material from the somatic cell to a recipient cell.
Patent NZ-518116-A (NZ)
Title: Bioavailable composition of natural and synthetic HCA
Inventor: MAJEED MUHAMMED
IPC: A61P3/04
Filed: 2001-08-17
Abstract: A composition comprising hydroxycitric acid (HCA) in combination with either one or both of garcinol and anthocyanin, and its use as a weight-loss therapy in animal subjects, preferably humans is disclosed. The therapeutics effects for the composition observed in murine and human studies include a reduction in total body weight and body mass index, a reduction in body fat, an increase in lean body mass and content of body water, and a reduction in perceived appetite level. Another composition for use in weight-loss thereapy is also described relating to forskolin in combination with either one or both of garcinol and anthocyanin. The anti-oxidant properties of garcinol are described as being enhanced in the presence of HCA and anthocyanin, and the combination of HCA, garcinol and anthocyanin is also shown to exert greater citrate lyase inhibiting properties than either compound alone. Methods of obtaining HCA, garcinol or anthocyanin, or a composition containing all three compounds, are described.
Patent NZ-532106-A (NZ)
Title: Gray water reuse apparatus with flow into gully and over filter and into container such that particulate can run off back down gulley outlet
Inventor: ROBERTS STEVEN JAMES
Filed: 2004-04-02
Abstract: Gray water flows via inlet pipe P and via diverter valve 17 to a mesh filter 24 and down to tank 12 for pumping via pump 35 and supply conduit C. Water can run off filter 24 to gulley outlet 16 to clean off particulate on the filter.
Patent NZ-534946-A (NZ)
Title: Fluorinated 4-azasteroid derivatives as androgen receptor modulators
Inventor: MEISSNER ROBERT S
IPC: A61P21/00
Filed: 2003-03-07
Abstract: Disclosed are compounds of formula (I) wherein: n is 0, 1 or 2; a-b represents CF=CH, CHFCH2, or CF2CH2; R1 is H, hydroxymethyl, or alkyl unsubstituted or substituted by F atoms; R2 is H; R3 is selected from alkyl, (CH2)n-cycloheteroalkyl, and (CH2)n-aryl, wherein aryl is as defined; or R2 and R3 together form a 5 or 6 membered saturated ring fused with a 5- or 6- membered aromatic ring system having 0, 1 or 2 heteroatoms selected from N, O, and S. Compounds of the type disclosed are androgen receptor modulators useful for treating conditions caused by androgen deficiency or ameliorated by androgen replacement.
Patent NZ-536161-A (NZ)
Title: Method and system for monitoring roadway freezing point based on temperature measurements and conductivity measurements
Inventor: LEONHARDT PATRICK A
Filed: 2002-11-01
Abstract: A method for measuring a liquid freezing point on a roadway, comprising sensor modules embedded in a roadway and connected via a two-conductor bus to each other (18) and to a network server (300), which may have internet connection. The sensor module (10) comprises a measurement zone on an upper surface (14), the lower body (12) of the module containing a temperature sensor in thermal contact with the measurement zone, a pair of conductivity probes in electrical contact with the measurement zone, and an active cooler thermally coupled to the measurement zone. The measurement zone is progressively cooled by the active cooler while the temperature sensor records temperature measurements and the conductivity probes record conductivity measurements. The freezing point of a liquid in the sample cup (16) of the measurement zone is then determined by a microprocessor within the module using algorithms analysing the variations in time of the temperature and conductivity measurements.
Patent NZ-540895-A (NZ)
Title: Purification of polypeptides with ethacridine lactate
Inventor: LESTER PHILIP M
IPC: C12P21/02
Filed: 2004-01-08
Abstract: A method for purifying a desired heterologous polypeptide from microbial fermentation broth or homogenate in which it is produced and solubilized is described. This method involves adding to the broth or homogenate an effective amount of a solution of 6,9-diamino-2-ethoxyacridine lactate (ethacridine lactate) to precipitate host cell impurities under conditions wherein the majority of polypeptide remains soluble, and separating the desired polypeptide from the broth or homogenate. The broth or homogenate containing the ethacridine lactate and polypeptide is also disclosed.
Patent NZ-547365-A (NZ)
Title: Tubing connection kit and method
Inventor: SHIPMAN JON
IPC: F16L25/14
Filed: 2004-10-21
Abstract: This discloses a kit of parts for use in fabricating an air-conditioning system comprising a tubing component 1' having at least two in-line sections with different external diameters and a set of connection means 3, each connection means 3 having dimensions such that it may be joined to the tubing component 1' at a respective section and enable connection to a pipe 2 of substantially the same diameter as the respective section.
Patent NZ-549081-A (NZ)
Title: Uses for proton pump inhibitors such as omeprazole for the treatment of metastatic tumours.
Inventor: FAIS STEFANO
IPC: A61P35/00
Filed: 2005-02-14
Abstract: Discloses the use of a proton pump inhibitor such as omeprazole in the manufacture of a medicament for ingestion for the treatment or prophylaxis of a cancerous condition which causes an acidic microenvironment, wherein the condition is a metastatic tumour.
Patent NZ-556097-A (NZ)
Title: Rnai modulation of RSV and therapeutic uses thereof
Inventor: MEYERS RACHEL
IPC: A61K31/70
Filed: 2006-01-06
Abstract: Provided is a composition comprising an iRNA agent, wherein the iRNA agent comprises a sense strand and an antisense strand, the antisense strand being less than 30 nucleotides in length and having at least 15 contiguous nucleotides complementary to a sequence from the N gene of Respiratory Syncytial Virus (RSV), wherein said sequence from the N gene of RSV includes the sequence GGCUCUUAGCAAAGUCAAG, and wherein the sense strand has at least 15 or more contiguous nucleotides complementary to said antisense strand. Further provided is use of the composition in the manufacture of a medicament for reducing the levels of RSV in patients.
Patent NZ-560872-A (NZ)
Title: Alkali resistant glass compositions
Inventor: HOJAJI HAMID
IPC: C03C3/087
Filed: 2006-02-24
Abstract: Disclosed is an alkali resistant glass, comprising: a silicate-containing glass body; a pre-formed passivity layer formed on an exterior surface of the silicate containing glass body, wherein the passivity layer is formed by hydrothermal treatment in a basic environment and has a composition that is different than the composition of the glass body, said passivity layer formed prior to use and comprising a substance that is native to the silicate-containing glass body, wherein the substance includes iron, calcium, magnesium or combinations thereof, wherein said substance in the passivity layer results in the passivity layer being substantially chemically inert in an alkaline environment. Also disclosed is a cementitious composite article comprising a cementitious material and a pre-formed alkali resistant glass additive comprising the alkali resistant glass disclosed above.
Patent NZ-572738-A (NZ)
Title: A star shaped biological cartridge filter with a handle
Inventor: HILL PAUL ALFRED
IPC: B01D29/33
Filed: 2008-11-11
Abstract: Disclosed is a biological cartridge filter for a sewage system. The filter includes an assembly formed from a star shaped in section columnar filter body perforated with a plurality of holes, a cylindrical outlet chamber perforated with a plurality of holes, a handle, a cap plate, an interchange plate and a base plate and connecting means. The handle includes a rod on which in vertical order the cap plate, outlet chamber, interchange plate, columnar filter body and base plate are fitted and locked together by the connecting means to form a biological filter assembly in which the star shaped in plan columnar filter body increases the capacity of the filter.
Patent NZ-573352-A (NZ)
Title: Substituted carboxamides as group i metabotropic receptor antagonists
Inventor: BACKER RYAN THOMAS
IPC: A61K31/425
Filed: 2007-06-07
Abstract: Disclosed is a substituted carboxamide compound of formula I, wherein the substituents are defined in the specification. Also disclosed is the use of the compound in the manufacture of a medicament for the treatment of pain.
Patent NZ-579725-A (NZ)
Title: Tablet composition having improved dissolution property
Inventor: KOJIMA MASAZUMI
IPC: A61K9/32
Filed: 2008-03-28
Abstract: Disclosed is a pharmaceutical composition comprising, as an active ingredient, N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{ [(5-methyl-4,5,6,7- tetrahydrothiazolo[5,4-c]pyridin-2-yl) carbonyl] amino} cyclohexyl) ethanediamide, represented by formula (1):, a pharmacologically acceptable salt thereof, or a hydrate of any of these, which composition is coated with at least one coating agent selected from among a cellulose derivative, a polyvinyl compound, an acrylate derivative, and a saccharide e.g. hypromellose, methyl cellulose, ethyl cellulose, hydroxypropyl cellulose, polyvinyl alcohol, povidone, Polyvinyl acetate, polyvinyl acetal diethylaminoacetate, aminoalkyl methacrylate copolymer RS, ethyl acrylate~methyl methacrylate copolymer dispersion, sucrose, and mannitol.
Patent NZ-582690-A (NZ)
Title: A composition comprising lercanidipine and an amount of a colloidal silicon dioxide from 5% to 25% by weight to enhance bioavailabilty and/or solubility
Inventor: KARAVAS EVANGELOS
IPC: A61K31/4422
Filed: 2008-07-23
Abstract: Disclosed is a pharmaceutical composition adapted for oral administration comprising Lercanidipine or a pharmaceutically acceptable salt, or polymorph thereof, as an active ingredient, and an amount of a colloidal silicon dioxide 5 from 5% to 25 % by weight to enhance bioavailability and/or improve solubility, wherein the composition further comprises a binder which is present in an amount of from 5% to 20% by weight and a disintegrant which is present in an amount of from 5% to 15% by weight.
Patent NZ-582798-A (NZ)
Title: Controlling substance application using sensors to test against predetermined condition parameters
Inventor: MACKENZIE CRAIGE HECTOR
IPC: A01M21/00
Filed: 2011-01-20
Abstract: Disclosed is an apparatus (1) for applying substances to an area of interest (13). The apparatus (1) includes one or more sensors (8, 10, 12) for sensing one or more sub-areas (14) of the area of interest (13). Each sensor (8, 10, 12) generates one or more detection signals each associated with a respective sub-area (14) upon detection of a sub-area (14) considered to have a chlorophyll intensity above a threshold level. The apparatus (1) also includes a control circuit (2) which produces a control signal associated with each detection signal and one or more outlets (7, 9, 11) responsive to control signals from the control circuit. The control circuit is operable in a first mode in which a control signal is applied to an outlet (7, 9, 11) to maintain it open except when a detection signal is present.
Patent NZ-586193-A (NZ)
Title: Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
Inventor: COSTANTINO PAOLO
IPC: A61K39/04
Filed: 2008-12-19
Abstract: Disclosed is a method for purifying a capsular polysaccharide from Streptococcus agalactiae comprising removing contaminating compounds from a solution comprising a capsular polysaccharide from Streptococcus agalactiae by filtration with an adherent filter, wherein said method does not comprise precipitating the capsular saccharide with a cationic detergent followed by re-solubilisation of the capsular saccharide.